- Home
- SVV vs ATAI Comparison
SVV vs ATAI Comparison
Compare SVV & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVV | ATAI |
|---|---|---|
| Founded | 1954 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SVV | ATAI |
|---|---|---|
| Price | $11.24 | $3.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $13.67 | ★ $13.86 |
| AVG Volume (30 Days) | 755.8K | ★ 3.6M |
| Earning Date | 02-19-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,616,273,000.00 | $3,018,000.00 |
| Revenue This Year | $17.32 | $956.49 |
| Revenue Next Year | $7.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.45 | ★ 811.78 |
| 52 Week Low | $6.48 | $1.15 |
| 52 Week High | $13.89 | $6.75 |
Technical Indicators
Market Signals| Indicator | SVV | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 46.11 |
| Support Level | $10.90 | $3.58 |
| Resistance Level | $11.41 | $4.01 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 44.30 | 55.07 |
Price Performance
Historical ComparisonAbout SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.